Wells Fargo’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-100
| Closed | – | – | 7214 |
|
|
2020
Q1 | $0 | Sell |
100
-200
| -67% | -$72 | ﹤0.01% | 7207 |
|
|
2019
Q4 | $0 | Hold |
300
| – | – | ﹤0.01% | 6963 |
|
|
2019
Q3 | $1K | Sell |
300
-400
| -57% | -$810 | ﹤0.01% | 6332 |
|
|
2019
Q2 | $2K | Hold |
700
| – | – | ﹤0.01% | 6206 |
|
|
2019
Q1 | $2K | Hold |
700
| – | – | ﹤0.01% | 5897 |
|
|
2018
Q4 | $2K | Hold |
700
| – | – | ﹤0.01% | 6232 |
|
|
2018
Q3 | $3K | Hold |
700
| – | – | ﹤0.01% | 6209 |
|
|
2018
Q2 | $3K | Hold |
700
| – | – | ﹤0.01% | 6170 |
|
|
2018
Q1 | $2K | Sell |
700
-100
| -13% | -$158 | ﹤0.01% | 6229 |
|
|
2017
Q4 | $1K | Hold |
800
| – | – | ﹤0.01% | 6297 |
|
|
2017
Q3 | $2K | Sell |
800
-160
| -17% | -$544 | ﹤0.01% | 6186 |
|
|
2017
Q2 | $4K | Buy |
960
+160
| +20% | +$580 | ﹤0.01% | 5977 |
|
|
2017
Q1 | $2K | Hold |
800
| – | – | ﹤0.01% | 6187 |
|
|
2016
Q4 | $2K | Hold |
800
| – | – | ﹤0.01% | 6120 |
|
|
2016
Q3 | $3K | Buy |
800
+100
| +14% | +$365 | ﹤0.01% | 6016 |
|
|
2016
Q2 | $4K | Hold |
700
| – | – | ﹤0.01% | 5870 |
|
|
2016
Q1 | $3K | Hold |
700
| – | – | ﹤0.01% | 5992 |
|
|
2015
Q4 | $6K | Buy |
+700
| New | +$5.84K | ﹤0.01% | 5860 |
|
Wells Fargo's CORV Position: Q2 2020 in Review
Wells Fargo sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 100 shares.
Wells Fargo first reported a position in CORV in Q4 2015 and held it in 18 quarters. The position peaked at $6K in Q4 2015. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.
- Wells Fargo reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
- Wells Fargo sold 100 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020.
- Wells Fargo first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2015 and held it in 18 quarters.
- Wells Fargo's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $6K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.
Based on Wells Fargo's 13F filing for Q2 2020, filed 13 Aug 2020.